The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share. That's up more than 20% from its IPO price of $29 per share. The company, which makes supplies products uh supplies and products used in labs and surgeries, sold more shares than initially planned in an upsized deal, more than $6 billion worth.Medline has been private for 58 years with most of its tenure familyowned until its buyout by a consortium of private equity firms in 2021. The IPO market cap is about 20 ...

Medline shares opened at $35 each, versus the IPO price of $29, after the medical supplier raised $6.26 billion in the year's biggest initial public offering. Bailey Lipschultz reports on Bloomberg Television. ...

The IPO of the year, the biggest one, uh, popping on its open last hours, just a few minutes ago, really after some middling performance in the IPO market generally. Is it a sign of pent-up demand into mega offerings like SpaceX next year. A sigh of relief for the private equity space, too.Leslie Picker has more over at the NASDAQ. Leslie, hey, Kelly, [music] yes. The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share.That's up more than 20% from its IPO price of $29 ...

The IPO of the year, the biggest one, uh, popping on its open last hours, just a few minutes ago, really after some middling performance in the IPO market generally. Is it a sign of pent-up demand into mega offerings like SpaceX next year. A sigh of relief for the private equity space, too.Leslie Picker has more over at the NASDAQ. Leslie, hey, Kelly, yes. The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share.That's up more than 20% from its IPO price of $29 per sha ...

Core Insights - Medline shares experienced a significant increase of nearly 25% during their trading debut, with the stock priced around $36 after an IPO that raised $6.26 billion, marking one of the largest IPOs in recent years [1][4][7] Company Overview - Medline sold over 216 million shares at $29 each, at the higher end of its anticipated range of $26 to $30, with plans to use the proceeds to reduce debt [2][4] - The company offers over 335,000 medical and surgical products, including protective equipment and testing kits, and has reported consistent annual sales growth since its inception [2] Financial Performance - For the first nine months of the year ending September, Medline reported a net income of $977 million on revenues of $20.65 billion, an increase from a net income of $911 million on $18.72 billion in revenue during the same period the previous year [3] Market Context - The IPO marks a recovery in the IPO market, although overall activity remains below the record levels seen in 2021; Medline's IPO is the largest since Rivian's $11.93 billion IPO in 2021 [4][7] Strategic Vision - CEO Jim Boyle expressed that the IPO is expected to enhance Medline's brand, positioning the company as the "Costco of healthcare" for its medical equipment customers, leveraging its private label products and strong supply chain [5]

Shares of Medline opened 20.7% above their offer price in their Nasdaq debut on Wednesday, giving the medical supply giant a valuation of $46.03 billion. ...

Core Insights - Medline is debuting on the Nasdaq after raising $6.26 billion in one of the largest IPOs in recent years, selling over 216 million shares at $29 each, at the higher end of its anticipated range [1][6] - The company plans to use the IPO proceeds to reduce its debt [1] Company Performance - Medline sells over 335,000 medical and surgical products and has reported consistent annual sales growth since its founding [2] - For the first nine months of the year ending in September, Medline reported a net income of $977 million on revenues of $20.65 billion, an increase from $911 million in net income on $18.72 billion in revenue during the same period the previous year [2] Market Context - Medline's IPO is part of a recovering IPO market, although overall activity remains below the record levels of 2021; the $6.26 billion raised is the largest since Rivian's IPO in 2021 [3] - CEO Jim Boyle stated that the IPO is expected to enhance Medline's brand, positioning the company as the "Costco of healthcare" for its customers [4]

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year. The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the IPO market in 2026. Shares of Medline will trade under the symbol "MDLN." The IPO pricing gives Medline a market value of at least $37 billion, based on the shares listed in its regul ...

It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...

Core Insights - Medline's shares surged 41% in their trading debut, closing at $41 after raising $6.26 billion in its IPO, marking one of the largest IPOs in recent years [1][4][7] Group 1: IPO Details - Medline sold over 216 million shares at $29 each, at the higher end of its anticipated range of $26 to $30 [2] - The proceeds from the IPO will be used to pay down some of the company's debts [2] Group 2: Financial Performance - For the first nine months of the year ending in September, Medline reported a net income of $977 million on revenue of $20.65 billion, an increase from $911 million on $18.72 billion in the same period the previous year [3] Group 3: Market Context - The IPO marks a recovery in the IPO market, although activity remains below the record levels seen in 2021 [4] - The $6.26 billion raised makes it the largest IPO since Rivian's $11.93 billion in 2021 [4] Group 4: Company Vision - CEO Jim Boyle stated that the IPO is expected to enhance Medline's brand, aiming to position the company as the "Costco of healthcare" for medical equipment buyers [5]